Clinical Trials Browser

NIH × Breast Neoplasms, Male × Imatinib Mesylate × Clear all

NCT00045188 2013-01-23

Imatinib Mesylate in Treating Patients With Metastatic Breast Cancer

Phase 2 Completed

Breast Neoplasms, Breast Neoplasms, Male